sanofi pasteur

Sanofi Pasteur Concludes Phase III Trial For Dengue Vaccine

The Phase III trial, which enrolled more than 10,000 children in Asia, showed that vaccination led to a 56 percent reduction in dengue cases.

Sanofi Pasteur, SK Chemicals To Co-Develop Pneumococcal Vaccine

Vaccine-maker Sanofi Pasteur will invest US$23 million in South Korea's SK Chemicals for the development of pneumococcal conjugate vaccine.

Sanofi Pasteur, Xiamen University To Develop Universal Flu Vaccine

Sanofi Pasteur and Xiamen University in China have agreed to jointly develop a universal flu vaccine.

Sanofi To Invest US$75 million Into Vietnam Manufacturing Facility

Sanofi announced on Friday the official launch of a construction project for a new manufacturing facility in Ho Chi Minh City.

Key Protein Makes Breast Cancer ‘Aggressive’

Australian scientists have discovered how a protein causes breast cancer to become more aggressive and resistant to common drugs.

Sanofi Pasteur’s Dengue Vaccine Shows Proof Of Efficacy: Study

The results of the world’s first dengue vaccine efficacy study confirm the safety of Sanofi Pasteur’s dengue vaccine against 3 out of 4 dengue virus serotypes.

Dengue Vaccine Shows Efficacy In Thai Clinical Trial: Sanofi Pasteur

Sanofi Pasteur announced on Thursday promising efficacy results of its dengue vaccine candidate in an efficacy trial conducted in Thailand.

Coalition Aims To Eradicate 10 Neglected Tropical Diseases By 2020

A large coalition of pharmas, governments, and NGOs have announced their goal of eliminating or controlling 10 neglected tropical diseases by 2020.

Sanofi And DNDi To Tackle Nine Neglected Tropical Diseases

Sanofi and the Drugs for Neglected Diseases initiative will develop new treatments for nine neglected tropical diseases listed by the World Health Organization.